(Q33939147)

English

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

hyperparathyroidism

1 reference

based on heuristic

inferred from title

author name string

G A Block

1

1 reference

Europe PubMed Central

30 July 2017

F K Port

2

1 reference

Europe PubMed Central

30 July 2017

publication date

1 June 2000

1 reference

Europe PubMed Central

30 July 2017

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

30 July 2017

35

1 reference

Europe PubMed Central

30 July 2017

6

1 reference

Europe PubMed Central

30 July 2017

1226-1237

1 reference

Europe PubMed Central

30 July 2017

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Are we mismanaging calcium and phosphate metabolism in renal failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of hematocrit on solute removal during high efficiency hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium acetate control of serum phosphorus in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical approach to the uraemic patient with extraskeletal calcifications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of excess PTH on nonclassical target organs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PTH--one can teach an old hormone new tricks

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of parathyroid hormone on myocardial energy metabolism in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial calcification and cardiac dysfunction in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperphosphataemia--a silent killer of patients with renal failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Arteriosclerosis in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of mitral and aortic valve sclerosis for survival in end-stage renal disease on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A case control study of proximal calciphylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calciphylaxis in a haemodialysis patient: functional protein S deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of niceritrol on faecal and urinary phosphate excretion in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium ketoglutarate versus calcium acetate for treatment of hyperphosphataemia in patients on maintenance haemodialysis: a cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin D analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcimimetics in action

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Daily hemodialysis: why the renewed interest?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970064-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0272-6386(00)70064-3

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33939147&oldid=1536147800"